Study on the interaction of three classical drugs used in psychiatry in albumin through spectrofluorimetric modeling
[Display omitted] •Drugs interactions with albumin were studied through Spectrofluorimetric Modeling.•Haloperidol, clonazepam and biperiden have high affinity for albumin.•Binding sites in albumin for HPD, CNP and BPD are located at subdomain IB and IIA. Comparative study of haloperidol (HPD), biper...
Gespeichert in:
Veröffentlicht in: | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy Molecular and biomolecular spectroscopy, 2021-07, Vol.255, p.119638, Article 119638 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•Drugs interactions with albumin were studied through Spectrofluorimetric Modeling.•Haloperidol, clonazepam and biperiden have high affinity for albumin.•Binding sites in albumin for HPD, CNP and BPD are located at subdomain IB and IIA.
Comparative study of haloperidol (HPD), biperiden (BPD) and clonazepam (CNZ) interactions with human and bovine serum albumin was performed based on fluorescence quenching analysis. We used mathematical modeling comparing spectrofluorimetric data to obtain information on the possibility of competition among three drugs by sites binding. Results showed that the three drugs studied have high affinity for albumin and suggest the existence of two site classes in HSA for HPD and only one class for BPD and CNZ, in the range of concentrations tested for each drug. Among them, only HPD forms complex with HSA. Comparing normalized quenching plots suggested that the primary sites in HSA and BSA for HPD and CNZ are located at subdomain IB, whereas BPD would bind in the subdomain IIA. Considering the competition for binding sites in HSA, titrations of HPD-HSA complex by BPD and CNZ, as well as the titration of HSA solution containing CNZ titrated by BPD, show that although the three drugs do not compete with each other for binding sites, their interaction with HSA can cause conformational change in the protein, and to increase or decrease the accessibility to binding sites for other drug. This may mean alteration in the free plasma drug concentrations. |
---|---|
ISSN: | 1386-1425 1873-3557 |
DOI: | 10.1016/j.saa.2021.119638 |